Testing effectiveness (Phase 2)Ended earlyNCT03827850What this trial is testingFGFR Inhibitor in FGFR Dysregulated CancerWho this might be right forLung CancerNSCLCPulmonary Neoplasm+2 more Lung Cancer Group Cologne 22
Testing effectiveness (Phase 2)Ended earlyNCT02489123What this trial is testingEnzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaWho this might be right forAnn Arbor Stage I Mantle Cell LymphomaAnn Arbor Stage II Mantle Cell LymphomaAnn Arbor Stage III Mantle Cell Lymphoma+3 more University of Washington 8
Early research (Phase 1)Looking for participantsNCT06227026What this trial is testingPilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma University of Utah 10
Testing effectiveness (Phase 2)Study completedNCT03664635What this trial is testingMB-CART20.1 LymphomaWho this might be right forRelapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaB-cell Lymphoma Refractory+1 more Miltenyi Biomedicine GmbH 10
Testing effectiveness (Phase 2)Ended earlyNCT02119676What this trial is testingStudy of Ruxolitinib in Colorectal Cancer PatientsWho this might be right forCRC (Colorectal Cancer) Incyte Corporation 396
Testing effectiveness (Phase 2)Ended earlyNCT00082017What this trial is testingUCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell LymphomasWho this might be right forLymphoma, Large-Cell, Ki-1Lymphoma, T-Cell National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT00559091What this trial is testingRibavirin to Treat M4 and M5 Acute Myelocytic LeukemiaWho this might be right forAcute Myelocytic Leukemia Jewish General Hospital 18
Testing effectiveness (Phase 2)UnknownNCT03902197What this trial is testingCD19 hsCAR-T for Refractory/Relapsed CD19+ B-ALL PatientsWho this might be right forAcute Lymphoblastic Leukemia Xuanwu Hospital, Beijing 50
Testing effectiveness (Phase 2)Study completedNCT00802113What this trial is testingAutologous and Allogeneic Transplant for Relapsed LymphomaWho this might be right forNon-Hodgkin's LymphomaHodgkins Disease Columbia University 30
Early research (Phase 1)UnknownNCT05007418What this trial is testingStudy to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Sorrento Therapeutics, Inc. 54
Testing effectiveness (Phase 2)Ended earlyNCT05272813What this trial is testingInvestigate the Efficacy and Safety of MS-553 in CLL/SLLWho this might be right forLymphocytic LeukemiaSmall Lymphocytic Lymphoma Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. 13
Testing effectiveness (Phase 2)UnknownNCT01002703What this trial is testingTreatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma University of Leipzig 50
Testing effectiveness (Phase 2)Study completedNCT03067155What this trial is testingCMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.Who this might be right forHematological MalignanciesCMV Infection University Hospital, Ghent 1
Early research (Phase 1)Ended earlyNCT04123418What this trial is testingWVT078 in Patients With Multiple Myeloma (MM)Who this might be right forMultiple Myeloma (MM) Novartis Pharmaceuticals 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07563010What this trial is testingMenin-Inhibitor Targeted Maintenance in AMLWho this might be right forRelapsed Adult AMLStem Cell Transplant ComplicationsAcute Myeloid Leukemia+1 more Center for International Blood and Marrow Transplant Research 146
Testing effectiveness (Phase 2)Study completedNCT00085813What this trial is testingIspinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung CancerWho this might be right forNon-Small-Cell Lung Cancer GlaxoSmithKline 70
Large-scale testing (Phase 3)Study completedNCT01197560What this trial is testingStudy of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)Who this might be right forDiffuse Large B-cell Lymphoma Celgene 111
Early research (Phase 1)WithdrawnNCT01130623What this trial is testingA Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid TumorsWho this might be right forSarcomaNeuroblastomaWilms Tumor+2 more National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT04874480What this trial is testingTegavivint for the Treatment of Relapsed or Refractory LeukemiaWho this might be right forRecurrent LeukemiaRefractory Leukemia M.D. Anderson Cancer Center 9
Early research (Phase 1)Looking for participantsNCT06799026What this trial is testingVaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple MyelomaRelapse Multiple MyelomaRefractory Multiple Myeloma David Avigan 25